Author: kwm107
-
Cella to Step Down as Chair of Medical Social Sciences
David Cella, PhD, the Ralph Seal Paffenbarger Professor, has announced that he will be stepping down as chair of the Department of Medical Social Sciences, the department he helped establish in 2009.
-
Predicting Which Glioblastoma Patients Will Respond to Immunotherapy
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
-
$12.5 Million to Fund ALS Research at Northwestern
Neurodegenerative Disease Research Inc. has made a five-year, $12.5 million philanthropic commitment to Northwestern to support research in amyotrophic lateral sclerosis (ALS) led by Teepu Siddique, MD.
-
Northwestern Receives Grant to Support Equity in Biomedicine
Northwestern University Feinberg School of Medicine has been awarded a $550,000 grant to support the retention of early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
-
Neurobiologists Identify a New Gene Important for Healthy Daily Rhythms
A recent study identified a gene that is critical for daily behavioral rhythms, involved in a molecular pathway by which the core circadian clock controls daily sleep-wake cycles.
-
Inge Joins Lurie Children’s Hospital as Surgeon-in-Chief
Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.
-
‘Dancing Molecules’ Successfully Repair Severe Spinal Cord Injuries
A new injectable therapy harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries, allowing animal subjects to regain the ability to walk.
-
A New Way to Improve Skilled Movements Via Sleep
The ability to learn novel physical movements, similar to those taught in rehabilitation for people with stroke, can be improved by reactivating specific memories of the new task during sleep, according to a new study.
-
Gene Therapy Boosts Parkinson’s Disease Drug Benefits
A new Northwestern Medicine study published in Nature explains why dopamine neurons are lost in Parkinson’s disease, and demonstrated that a gene therapy targeting the brain’s substantia nigra can substantially boost the benefits of levodopa, an important medication for treating the disease.
-
Feinberg MD Program Receives Full LCME Accreditation
Northwestern University Feinberg School of Medicine has received a full eight-year accreditation by the Liaison Committee of Medical Education, the accrediting authority for medical education programs leading to the MD degree.
